Invention Application
- Patent Title: ANTI-IL36R ANTIBODIES
-
Application No.: PCT/US2019/041952Application Date: 2019-07-16
-
Publication No.: WO2020018503A3Publication Date: 2020-01-23
- Inventor: FAIRHURST, Jeanette , GARNOVA, Elena , OLSON, William , HAXHINASTO, Sokol
- Applicant: REGENERON PHARMACEUTICALS, INC.
- Applicant Address: 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 US
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: 777 Old Saw Mill River Road Tarrytown, NY 10591-6707 US
- Agency: GROLZ, Edward, W.
- Priority: US62/698,482 20180716; US62/846,989 20190513; US62/866,028 20190625
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61P37/06 ; A61P17/06
Abstract:
The present invention provides antibodies and antigen-binding fragments ( e.g. , human antibodies) that bind specifically to human IL-36 receptor. Methods for treating or preventing diseases mediated by IL36R ( e.g ., skin or colon inflammatory conditions such as palmo-plantar pustular psoriasis, palmoplantar pustulosis, generalized pustular psoriasis, ulcerative colitis or IBD) using the antibodies and fragments are also provided along with methods of making the antibodies and fragments.
Public/Granted literature
- WO2020018503A2 ANTI-IL36R ANTIBODIES Public/Granted day:2020-01-23
Information query